News | Intra-Aortic Balloon Pumps (IABP) | September 24, 2018

Getinge Issues Worldwide Voluntary Correction of Maquet/Getinge Cardiosave Intra-Aortic Balloon Pump

Company reports device may interrupt or be unable to start therapy at altitudes above 3,200 feet; users cautioned to follow advised operating altitudes

Getinge Issues Worldwide Voluntary Correction of Maquet/Getinge Cardiosave Intra-Aortic Balloon Pump

September 24, 2018 — Getinge is voluntarily initiating a worldwide recall involving a field correction of approximately 5,223 Maquet/Getinge Cardiosave Intra-Aortic Balloon Pumps (IABP) sold by Datascope Corp. The correction involves a potential interruption and/or inability to start therapy to the patient regarding the use of certain IABs prior to or during the use with Cardiosave IABP for users who are at altitudes above 3,200 feet/975 meters. This condition could potentially lead to patient hemodynamic instability.

It is important to note, there have been no adverse events or deaths attributed to this issue.

Affected Product
Part Number
Distribution Date

Cardiosave Hybrid IABP
0998-00-0800-XX
March 6, 2012 to Aug. 31, 2018

Cardiosave Rescue IABP
0998-UC-0800-XX

IABs used with the CS100 or CS300 IABPs are not affected by this issue. Interim immediate actions for consumers who have Cardiosave IABPs include:

The only action to be taken by the user for this issue is to follow the operating altitudes as specified below for the Cardiosave IABP.

Balloon Name and Size
Operating Altitude

Sensation 34cc / 40cc,
-1,250 feet to 3,200 feet (795 mmHg to 676 mmHg) (1,060 hPa to 901 hPa)

Sensation Plus 40cc / 50cc
-381 to 975 meters (795 mmHg to 676 mmHg) (1,060 hPa to 901 hPa)

Mega 50cc
-1,250 feet to 5,000 feet (795 mmHg to 632 mmHg) (1,060 hPa to 843 hPa)

-381 to 1,524 meters (795 mmHg to 632 mmHg) (1,060 hPa to 843 hPa)

Mega 30cc / 40cc
-1,250 feet to 12,000 feet (795 mmHg to 483 mmHg) (1,060 hPa to 644 hPa)

Linear 25cc / 34cc / 40cc
-381 to 3,657 meters (795 mmHg to 483 mmHg) (1,060 hPa to 644 hPa

 

For Japan users only

Balloon Name and Size
Operating Altitude

TransRay 34cc / 40cc,
-381 to 975 meters (795 mmHg to 676 mmHg) (1,060 hPa to 901 hPa)

TransRay Plus 35cc / 40cc

Yamato Plus N or R 30cc / 35cc / 40cc
-381 to 3,657 meters (795 mmHg to 483 mmHg) (1,060 hPa to 644 hPa)

Alternatively, use a CS100 or CS300 IABP since they are not affected by this issue.

Maquet/Getinge is currently developing a software correction to address the altitude issue. Maquet/Getinge anticipates the installation of the updated software to begin February 2019. A Maquet/Getinge Service representative will contact affected customers to schedule the installation of the updated software.

Customers with questions may contact the company via telephone (973) 709-7967, Monday through Friday, between the hours of 8 a.m. and 6 p.m. EST. or via e-mail at [email protected]

Adverse reactions or quality problems experiences with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.

For more information: www.getinge.com

Read about the warning letter about Maquet IABPs shutting off while operationg on battery power (Nov. 1, 2018)

 

 

Related Content

Sponsored Content | Videos | Cath Lab | October 24, 2018
Michael Flaherty, M.D., discusses a study published in Circulation Research which finds that use of hemodynamic suppo
Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cath Lab | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...
Sponsored Content | Videos | Cath Lab | September 19, 2018
William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ) datab
A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. DAIC staff photo by Dave Fornell

A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. (right) who is proctoring a fellow in treating CTOs.

Feature | Cath Lab | September 13, 2018 | Artur Kim, Kamran Zamanian
Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and tre
Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
Overlay Init